Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06960499

Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy

Introduction. The development of hemophilic arthropathy causes degenerative joint damage that leads to functional impairment, limiting physical activity and causing disability in patients with hemophilia.

Objectives. i) To assess the level of physical activity in patients with hemophilia; ii) To identify the best predictive model for physical activity in adult patients with hemophilic arthropathy.

Material and method. Multicenter cross-sectional cohort study. Eighty-eight patients will be recruited. The dependent variable will be physical activity (International Physical Activity Questionnaire). Secondary variables will be kinesiophobia (Tampa Kinesiophobia Scale), functionality (Functional Independence Scale in Hemophilia), pain intensity, and clinical, anthropometric, and sociodemographic variables.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with hemophilia A or B
  • Over the age of majority
  • With a medical diagnosis of severe phenotype of the disease
  • With a medical diagnosis of hemophilic arthropathy in the lower limbs
  • Under on-demand or prophylactic drug treatment.

Exclusion criteria

  • Patients who require technical aids for walking
  • Patients who are dependent for activities of daily living
  • Patients over the age of 60
  • Patients with cognitive impairments that prevent them from understanding the questionnaires

Treatment and study plan

Surveys

Other

No intervention will be carried out in this study; the recruited patients will only complete the questionnaires provided below

Primary outcomes

  1. Measurement of physical activity level

    Time frame: Screening visit

    Physical activity levels will be assessed using the International Physical Activity Questionnaire (IPAQ). This tool assesses physical activity levels in adults aged 18 to 65. It consists of seven questions that ask about the frequency, duration, and intensity of physical activity performed in the last week. It also assesses the time spent walking and sitting. The results are classified into three categories: low, moderate, and high activity. The unit of measurement is metabolic equivalent task (METS), where a higher number of METS indicates greater physical activity.

Secondary outcomes

  1. Measurement of fear of movement

    Time frame: Screening visit

    Fear of movement will be measured using the Tampa Kinesiophobia Scale (TSK). This self-reported questionnaire consists of 17 items, using a 4-point Likert scale. It comprises two subscales: avoidance of physical exertion due to fear of injury or pain, and belief that significant underlying medical problems exist. The total score ranges from 17 to 68 points, with a score of 37 or more indicating a high level of kinesiophobia

  2. Measurement of degree of functional independence

    Time frame: Screening visit

    The degree of functional independence of patients will be measured using the Functional Independence Scale for Hemophilia (FISH). This tool measures eight activities of daily living: eating, personal hygiene, dressing, transferring from a chair, squatting, walking, climbing stairs, and running. Each activity is rated according to the level of assistance required, using a scale from 1 to 4. The total score can reach a maximum of 32 points, with a higher score indicating greater functional independence.

  3. Measurement of the joint pain

    Time frame: Screening visit

    Pain intensity will be measured using the Visual Analog Scale (VAS). This is a simple and effective tool for measuring pain intensity. It consists of a horizontal line, usually 10 cm long, with one end representing "no pain" and the other "maximum pain imaginable."

  4. Measurement of age

    Time frame: Screening visit

    The sociodemographic variable age will be measured in months completed from the date of birth

  5. Measurement of marital status

    Time frame: Screening visit

    The sociodemographic variable marital status will be measured as a qualitative variable (single/married/divorced/widowed).

  6. Measurement of educational level

    Time frame: Screening visit

    The sociodemographic variable educational level will be measured as a qualitative variable (primary education/secondary education/university education/vocational training).

  7. Measurement of employment status

    Time frame: Screening visit

    The sociodemographic variable employment status will be measured as a qualitative variable (self-employed/employed by others/civil servant/unemployed/unable to work/retired).

  8. Measurement of hemophilia type

    Time frame: Screening visit

    The clinical variable hemophilia type will be measured as a dichotomous variable (hemophilia A/hemophilia B).

  9. Measurement of type of drug treatment

    Time frame: Screening visit

    The clinical variable drug treatment will be measured as a dichotomous variable (on-demand treatment/prophylactic treatment).

  10. Measurement of inhibitor development

    Time frame: Screening visit

    The clinical variable development of antibodies prior to FVIII/FIX concentrates (inhibitors) will be measured as a dichotomous variable (yes/no).

  11. Measurement of weight

    Time frame: Screening visit

    The anthropometric variable weight will be measured as a quantitative variable (measured in kg).

  12. Measurement of height

    Time frame: Screening visit

    The anthropometric variable height will be measured as a quantitative variable (measured in cm).

Study contacts

Contact information is provided by the study sponsor or research team.

Rubén Cuesta-Barriuso, PhD

CONTACT

[email protected]

607547274

Sponsors and collaborators

Lead sponsor

Universidad Católica San Antonio de Murcia

Other

Registry information

Official study title

Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy. A Multicenter Cross-sectional Cohort Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 7, 2025
Registry last updated
May 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.